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mARDIOVASCULAR GENOMIC MEDICINE1089Genomics and Cardiovascular Drug Developmentndrew S. Plump, Pek Yee Lum
he process of drug development has become increasingly difficult and expensive in the post-
tatin era. Plump and Lum review how the broad field of genomics may lead to new drug
lasses and to improved clinical success rates for drug candidates. The most prominent
oadblocks to cardiovascular (CV) drug development outlined include the dearth of valid drug
argets and pre-clinical models that predict efficacy and safety in humans, the need to develop
iomarkers that predict relevant CV clinical outcomes, and the knowledge to understand how
enetic differences in patients alter candidate drug efficacy. The genomic approaches that are
urrently being applied in industry, biotechnology, and academic settings to address many of
hese gaps are reviewed.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY
1101riple Therapy With Cilostazol Inhibits
Platelets More Than Double-Dose Clopidogrel0
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20 mol/l ADP-induced Aggmax> 50%oung-Hoon Jeong, Seung-Whan Lee, Bong-Ryong Choi, In-Suk Kim, Myung-Ki Seo, Choong Hwan Kwak,
in-Yong Hwang, Seong-Wook Park
his study assessed the effect of adjunctive cilostazol on platelet inhibition in patients with
igh post-treatment platelet reactivity (HPPR), commonly referred to as clopidogrel
onresponders. Jeong and colleagues compared the degree of platelet inhibition achieved by
dding cilostazol 100 mg twice daily to the usual doses of aspirin and clopidogrel or doubling
he dose of clopidogrel to 150 mg/day in patients with HPPR after clopidogrel loading. After
0 days, significantly fewer patients assigned to cilostazol still had HPPR (3.3% vs. 27%).
mong patients with HPPR, adjunctive cilostazol may be more effective than a higher
aintenance dose of clopidogrel.(continued on page A-22)
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wTHEROSCLEROSIS1110Both LDL-C and Blood Pressure Affect Progression of Coronary AtherosclerosisEditorial Comment
Jonathan M. Tobis anddnan K. Chhatriwalla, Stephen J. Nicholls, Thomas H. Wang, Kathy Wolski, Ilke Sipahi, Tim Crowe,
aul Schoenhagen, Samir Kapadia, E. Murat Tuzcu, Steven E. Nissen
hhatriwalla and colleagues studied the impact of lowering both low-density lipoprotein
holesterol (LDL-C) and systolic blood pressure (SBP) on rates of coronary plaque
rogression using intravascular ultrasound. Patients with very low LDL-C (70
g/dl) and normal SBP (120 mm Hg) had less progression in percent atheroma volume
PAV), more frequent plaque regression, and less frequent plaque progression. In patients
ith SBP 120 mm Hg, very low LDL-C was associated with less progression of PAV; in
atients with LDL-C 70 mg/dl, SBP did not affect PAV. Very low LDL-C and normal
BP are associated with the slowest progression of coronary atherosclerosis, suggesting the
eed for intensive and simultaneous control of blood pressure and LDL-C.EART FAILURE
1119ulmonary Hypertension Is Common in Patients
With Heart Failure and Preserved Ejection Fraction15 25 35 45
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Editorial Commentarloyn S. P. Lam, Véronique L. Roger, Richard J. Rodeheffer, Barry A. Borlaug, Felicity T. Enders,
argaret M. Redfield
igh left atrial pressure leads to higher post-capillary pulmonary pressures. Lam and
olleagues hypothesized that this post-capillary pressure can lead to increased pulmonary
rterial tone or intrinsic arterial remodeling, which could result in a superimposed pre-
apillary component of pulmonary hypertension (PH). Echocardiograms from subjects with a
istory of hypertension (HTN) but not heart failure were compared with a group of subjects
ith heart failure with preserved ejection fraction (HFpEF). Pulmonary artery systolic
ressure (PASP) was estimated from the tricuspid regurgitant jet and pulmonary capillary
edge pressure (PCWP) from E/e=. In HFpEF, PH was much more frequent than in those
ith only HTN. After adjusting for PCWP, PASP was still higher in HFpEF subjects,
uggesting that reactive pulmonary arterial hypertension may lead to heart failure in subjects
ith HTN.(continued on page A-23)
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sEART RHYTHM DISORDERS1130Post-Exercise T-Wave Alternans May Improve Risk Stratificationichael P. Slawnych, Tuomo Nieminen, Mika Kähönen, Katherine M. Kavanagh, Terho Lehtimäki,
arlene Ramadan, Jari Viik, Sandeep G. Aggarwal, Rami Lehtinen, Linda Ellis, Kjell Nikus,
erek V. Exner, for the REFINE (Risk Estimation Following Infarction Noninvasive Evaluation)
nd FINCAVAS (Finnish Cardiovascular Study) Investigators
he modified moving average (MMA) method for measuring T-wave alternans (TWA)
eparates odd from even beats to allow direct comparison of their average morphologies. The
mmediate post-exercise period, where increased physiologic stress and minimal surface
rtifact coexist, appears ideal to implement the MMA method. Almost 1,000 patients were
ested for the ability of MMA TWA to predict cardiovascular death in patients with known
oronary artery disease (CAD). A linear relationship between the magnitude of TWA and
he risk of cardiovascular disease was identified, with similar discriminatory value to ejection
raction. An MMA of 60 V had 95% specificity for predicting cardiovascular death. Post-
xercise assessment of TWA using the MMA method is a strong, independent predictor of
isk in patients with CAD.ARDIAC IMAGING
1138elayed-Enhanced Magnetic Resonance
Imaging Can Be Used to Guide VT Ablation ProceduresEditorial Comment
Alan H. Kadish andrank M. Bogun, Benoit Desjardins, Eric Good, Sanjaya Gupta, Thomas Crawford, Hakan Oral,
atthew Ebinger, Frank Pelosi, Aman Chugh, Krit Jongnarangsin, Fred Morady
ogun and colleagues studied whether delayed-enhanced magnetic resonance imaging
DE-MRI) could facilitate mapping for ventricular tachycardia (VT) ablation procedures
n patients with nonischemic cardiomyopathies. Scar tissue location was extracted from
E-MRIs and integrated with the electroanatomic map obtained during the procedure.
ne-half of these patients had significant scar tissue, and these areas were electrically
ritical in all patients who had successful ablations. The ablation was more likely to be
uccessful if the scar was endocardial. DE-MRI can help to identify the arrhythmogenic
ubstrate in patients with nonischemic cardiomyopathies and to estimate the likelihood of
uccess for ablation procedures.(continued on page A-24)
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MAdonen Jaffe, General Leung, Nigel R. Munce, Amandeep S. Thind, Howard Leong-Poi,
evan J. T. Anderson, Xiuling Qi, Judy Trogadis, Ariella Nadler, Davida Shiff, Jamie Saperia,
ulia Lockwood, Chaim Jacobs, Beiping Qiang, Aaron Teitelbaum, Alexander J. Dick, John D. Sparkes,
agdish Butany, Graham A. Wright, Bradley H. Strauss
ngioplasty success rates for chronic total occlusions (CTOs) are inversely related to the age
f the occlusion, suggesting that these lesions mature over time. Jaffe and colleagues used an
nimal model of acute thrombotic occlusion to study CTOs. The early stage (2 to 6 weeks)
as characterized by an acute inflammatory response and patchy formation of an extracellular
atrix within the thrombotic occlusion. During the intermediate stage (6 to 12 weeks), there
as negative arterial remodeling and intraluminal neovascularization. By 12 weeks, the
hrombotic occlusion was replaced with an avascular collagen-enriched matrix, which
roduced a hard proximal fibrous cap. This proximal fibrous cap likely inhibits passage of a
uidewire across mature CTOs.
